Follow
Ji Young Yoo
Title
Cited by
Cited by
Year
Inhibition of SOAT1 suppresses glioblastoma growth via blocking SREBP-1–mediated lipogenesis
F Geng, X Cheng, X Wu, JY Yoo, C Cheng, JY Guo, X Mo, P Ru, B Hurwitz, ...
Clinical Cancer Research 22 (21), 5337-5348, 2016
2512016
Glucose-mediated N-glycosylation of SCAP is essential for SREBP-1 activation and tumor growth
C Cheng, P Ru, F Geng, J Liu, JY Yoo, X Wu, X Cheng, V Euthine, P Hu, ...
Cancer cell 28 (5), 569-581, 2015
2332015
VEGF-specific short hairpin RNA–expressing oncolytic adenovirus elicits potent inhibition of angiogenesis and tumor growth
JY Yoo, JH Kim, YG Kwon, EC Kim, NK Kim, HJ Choi, CO Yun
Molecular Therapy 15 (2), 295-302, 2007
1772007
MicroRNAs/TP53 feedback circuitry in glioblastoma multiforme
SS Suh, JY Yoo, GJ Nuovo, YJ Jeon, S Kim, TJ Lee, T Kim, A Bakācs, ...
Proceedings of the National Academy of Sciences 109 (14), 5316-5321, 2012
1602012
RNA Nanoparticle-Based Targeted Therapy for Glioblastoma through Inhibition of Oncogenic miR-21
CCM Lee TJ, Yoo JY, Shu D, Li H, Zhang J, Yu JG, Jaime-Ramirez AC, Acunzo M ...
Molecular Therapy, 2017
1342017
PRMT5–PTEN molecular pathway regulates senescence and self-renewal of primary glioblastoma neurosphere cells
YK Banasavadi-Siddegowda, L Russell, E Frair, VA Karkhanis, T Relation, ...
Oncogene 36 (2), 263-274, 2017
1182017
Effective treatment of an orthotopic xenograft model of human glioblastoma using an EGFR-retargeted oncolytic herpes simplex virus
H Uchida, M Marzulli, K Nakano, WF Goins, J Chan, CS Hong, ...
Molecular Therapy 21 (3), 561-569, 2013
1182013
Short hairpin RNA-expressing oncolytic adenovirus-mediated inhibition of IL-8: effects on antiangiogenesis and tumor growth inhibition
JY Yoo, JH Kim, J Kim, JH Huang, SN Zhang, YA Kang, H Kim, CO Yun
Gene therapy 15 (9), 635-651, 2008
1172008
Effect of decorin on overcoming the extracellular matrix barrier for oncolytic virotherapy
IK Choi, YS Lee, JY Yoo, AR Yoon, H Kim, DS Kim, DG Seidler, JH Kim, ...
Gene therapy 17 (2), 190-201, 2010
1142010
Optimizing DC vaccination by combination with oncolytic adenovirus coexpressing IL-12 and GM-CSF
SN Zhang, IK Choi, JH Huang, JY Yoo, KJ Choi, CO Yun
Molecular Therapy 19 (8), 1558-1568, 2011
1072011
RNA nanoparticle as a vector for targeted siRNA delivery into glioblastoma mouse model
TJ Lee, F Haque, D Shu, JY Yoo, H Li, RA Yokel, C Horbinski, TH Kim, ...
Oncotarget 6 (17), 14766, 2015
1002015
The impact of macrophage-and microglia-secreted TNFα on oncolytic HSV-1 therapy in the glioblastoma tumor microenvironment
WH Meisen, ES Wohleb, AC Jaime-Ramirez, C Bolyard, JY Yoo, ...
Clinical Cancer Research 21 (14), 3274-3285, 2015
842015
Feedback loop regulation of SCAP/SREBP-1 by miR-29 modulates EGFR signaling-driven glioblastoma growth
P Ru, P Hu, F Geng, X Mo, C Cheng, JY Yoo, X Cheng, X Wu, JY Guo, ...
Cell reports 16 (6), 1527-1535, 2016
832016
An oncolytic herpesvirus expressing E-cadherin improves survival in mouse models of glioblastoma
B Xu, R Ma, L Russell, JY Yoo, J Han, H Cui, P Yi, J Zhang, H Nakashima, ...
Nature biotechnology 37 (1), 45-54, 2019
752019
Bortezomib-induced unfolded protein response increases oncolytic HSV-1 replication resulting in synergistic antitumor effects
JY Yoo, BS Hurwitz, C Bolyard, JG Yu, J Zhang, K Selvendiran, KS Rath, ...
Clinical cancer research 20 (14), 3787-3798, 2014
752014
Bortezomib treatment sensitizes oncolytic HSV-1–treated tumors to NK cell immunotherapy
JY Yoo, AC Jaime-Ramirez, C Bolyard, H Dai, T Nallanagulagari, ...
Clinical Cancer Research 22 (21), 5265-5276, 2016
742016
FHIT suppresses epithelial-mesenchymal transition (EMT) and metastasis in lung cancer through modulation of microRNAs
SS Suh, JY Yoo, R Cui, B Kaur, K Huebner, TK Lee, RI Aqeilan, CM Croce
PLoS genetics 10 (10), e1004652, 2014
732014
Suicide cancer gene therapy using pore-forming toxin, streptolysin O
WS Yang, SO Park, AR Yoon, JY Yoo, MK Kim, CO Yun, CW Kim
Molecular cancer therapeutics 5 (6), 1610-1619, 2006
722006
Efficacy of onalespib, a long-acting second-generation HSP90 inhibitor, as a single agent and in combination with temozolomide against malignant gliomas
A Canella, AM Welker, JY Yoo, J Xu, FS Abas, D Kesanakurti, ...
Clinical Cancer Research 23 (20), 6215-6226, 2017
692017
840. Markedly Enhanced Cytolysis by E1B-19kD-Deleted Oncolytic Adenovirus in Combination with Cisplatin
AR Yoon, YS Lee, JY Yoo, H Kim, J Kim, JB Ahn, JH Kim, CO Yun
Molecular Therapy 13, S325, 2006
692006
The system can't perform the operation now. Try again later.
Articles 1–20